4 unchanged sentences
Moreover, we do not believe that any institutional or other large-scale trading of our stock has occurred or will in fact occur in the near future.
−Removed: The following table sets forth information as reported by the OTC Markets Group through February 14, 2019 and the Nasdaq Capital Markets for the period beginning February 15, 2019 for the high and low bid and ask prices for each of the eight quarters ending December 31, 2021 for our common stock.
+Added: The following table sets forth information as reported by the Nasdaq Capital Markets for the high and low bid and ask prices for each of the eight quarters ending December 31, 2024 for our common stock.
The following prices reflect inter-dealer prices without retail markup, markdown or commissions and may not reflect actual transactions.
1 unchanged sentence
Quarters ending in 2023
−Removed: As of March 28, 2022, the Company had 153 Class A Common Stock shareholders of record holding 65,742,185 shares of our Class A Common Stock issued and outstanding.
+Added: As of December 31, 2024, the Company had 131 Class A Common Stock shareholders of record holding 78,017,047 shares of our Class A Common Stock issued and outstanding.
This number includes one position at Cede & Co., which includes an unknown number of shareholders holding shares of 53,816,546 Class A Common Stock.
9 unchanged sentences
Effective, February 15, 2019, The Company’s Common Stock began trading on the NASDAQ Capital Market.
−Removed: The Company received a failure to comply with Nasdaq minimum bid pricing letter on October 7, 2019 which was cleared on April 9, 2020.
−Removed: On January 6, 2021, the Company received a notice of deficiency related to Nasdaq’s required annual shareholder meeting standards which was cleared on April 26, 2021.
Recent Sales of Unregistered Securities.
8 unchanged sentences
Based on an analysis of the above factors, we believe we have met the requirements to qualify for exemption under section 4(a)(2) of the Securities Act of 1933 for this transaction.
−Removed: On May 8, 2020, the Company received 2,000,000 shares of Class A Common Stock pursuant to the agreement of Sale for the Empire Assets.
−Removed: The share price at return was $0.92.
−Removed: On October 8, 2020, the Company issued 5,200,000 shares of Class A Common Stock at a price of $2.50 per share in conjunction with its effective S-3/A Registration Statement.
−Removed: Net proceeds to the Company amounted to $12,030,000.
−Removed: During 2020, the Company issued 2,608,653 share of Class A Common Stock pursuant to warrant conversions.
During 2023, the Company issued 9,420,230 shares of Class A Common Stock pursuant to debt conversions.
−Removed: During 2020, the Company issued 15,000 shares of Class A Common Stock pursuant to various consulting arrangements.
−Removed: During 2020, the Company issued 15,000 shares of Class A Common Stock pursuant to various consulting arrangements.
−Removed: During 2020, the Company issued 229,373 shares of Class A Common Stock pursuant to payable conversions.
−Removed: On March 17, 2021, 425,000 of restricted common shares were sold.
−Removed: Gross proceeds to the Company amounted to $1,275,000.
−Removed: On June 9, 2021, the Company issued 8,600,000 shares of Class A Common Stock.
−Removed: Net proceeds to the Company after offering expenses amounted to $27,943,000.
−Removed: During 2021, the Company issued 3,826,532 share of Class A Common Stock pursuant to warrant conversions.
+Added: During 2023, the Company issued 49,020 shares of Class A Common Stock pursuant to consulting arrangements.
+Added: During 2024, the Company re-purchased 86,410 shares of Class A Common Stock pursuant to stock re-purchase program.
+Added: During 2024, the Company issued 902,419 shares of Class A Common Stock pursuant to warrant conversions.
During 2024, the Company issued 595,790 shares of Class A Common Stock pursuant to debt conversions.
During 2024, the Company issued 102,500 shares of Class A Common Stock pursuant to various consulting arrangements.
+Added: During 2024, the Company issued 148,000 shares of Class A Common Stock pursuant to the exercise of stock options.
SERIES A PREFERRED STOCK
36 unchanged sentences
OPTIONS AND WARRANTS
−Removed: On June 18, 2020, the Board issued a total of 750,000 options to 2 employees of the Company under the 2018 Plan.
−Removed: The options have an expiration date of June 17, 2027 and have an exercise price of $2.630.
−Removed: The options vested equally over the course of seven years, subject to restrictions regarding the employee’s continued employment by the Company.
−Removed: On July 16, 2020, the Board issued a total of 50,000 options to a director of the Company under the 2018 Plan as amended.
−Removed: The options have an expiration date of March 15, 2021 and vest immediately.
−Removed: On November 23, 2020, the Board issued a total of 302,439 options to 3 employees and 4 directors.
−Removed: The options have an expiration of November 22, 2027 and vest immediately.
−Removed: On February 3, 2020 Warrant C-5 was issued in connection to the conversion of $9,494,073 of outstanding debt into the senior convertible note.
−Removed: Warrant C-5 is for 949,407 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of February 3, 2023.
−Removed: On February 20, 2020 Warrant C-6 was issued in connection to the purchase of $200,000 of the senior convertible notes.
−Removed: Warrant C-6 is for 20,000 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of February 20, 2022.
−Removed: On April 1, 2020 Warrant C-7 was issued in connection to the conversion of $375,690 of outstanding debt into the senior convertible notes.
−Removed: Warrant C-7 is for 37,569 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of April 1, 2022.
−Removed: On April 1, 2020 Warrant C-8 was issued in connection to the conversion of $225,000 of outstanding debt into the senior convertible notes.
−Removed: Warrant C-8 is for 22,500 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of April 1, 2022.
−Removed: On April 1, 2020 Warrant C-9 was issued in connection to the conversion of $900,000 of outstanding debt into the senior convertible notes.
−Removed: Warrant C-9 is for 90,000 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of April 1, 2022.
−Removed: On April 1, 2020 Warrant C-10 was issued in connection to the conversion of $1,888,444 of outstanding debt into the senior convertible notes.
−Removed: Warrant C-10 is for 188,844 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of April 1, 2022.
−Removed: On April 1, 2020 Warrant C-11 was issued in connection to the conversion of $200,000 of outstanding debt into the senior convertible notes.
−Removed: Warrant C-11 is for 20,000 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of April 1, 2022.
−Removed: On April 1, 2020 Warrant C-12 was issued in connection to the conversion of $110,000 of outstanding debt into the senior convertible notes.
−Removed: Warrant C-12 is for 11,000 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of April 1, 2022.
−Removed: On April 1, 2020 Warrant C-13 was issued in connection to the purchase of $22,500 of the senior convertible notes.
−Removed: Warrant C-13 is for 2,250 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of April 1, 2022.
−Removed: On April 14, 2020 Warrant C-15 was issued in connection to the purchase of $53,639 of the senior convertible notes.
−Removed: Warrant C-15 is for 5,364 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of April 14, 2022.
−Removed: On April 14, 2020 Warrant C-16 was issued in connection to the purchase of $5,000 of the senior convertible notes.
−Removed: Warrant C-16 is for 500 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of April 14, 2022.
−Removed: On June 1, 2020 Warrant A-9 was issued in connection to legal services provided.
−Removed: Warrant A-9 is for 100,000 warrant shares.
−Removed: The warrants carry an exercise price of $1.00 and an expiration date of June 1, 2022.
−Removed: On June 1, 2020 Warrant C-18 was issued in connection to the issuance of $2,000 of the senior convertible notes.
−Removed: Warrant C-18 is for 200 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of June 1, 2022.
−Removed: On June 5, 2020 Warrant C-27 was issued in connection to the issuance of $2,000 of the senior convertible notes.
−Removed: Warrant C-27 is for 200 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of June 5, 2022.
−Removed: On June 11, 2020 Warrant C-19 was issued in connection to the issuance of $1,019,573 of the senior convertible notes.
−Removed: Warrant C-19 is for 101,957 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of June 11, 2022.
−Removed: On June 11, 2020 Warrant C-20 was issued in connection to the issuance of $474,996 of the senior convertible notes.
−Removed: Warrant C-20 is for 47,500 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of June 11, 2022.
−Removed: On June 15, 2020 Warrant C-23 was issued in connection to the issuance of $2,000 of the senior convertible notes.
−Removed: Warrant C-23 is for 200 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of June 15, 2022.
−Removed: On June 16, 2020 Warrant C-24 was issued in connection to the issuance of $12,154 of the senior convertible notes.
−Removed: Warrant C-24 is for 1,215 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of June 16, 2022.
−Removed: On June 22, 2020 Warrant C-21 was issued in connection to the purchase of $180,000 of the senior convertible notes.
−Removed: Warrant C-21 is for 18,000 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of June 30, 2022.
−Removed: On June 23, 2020 Warrant C-25 was issued in connection to the issuance of $2,000 of the senior convertible notes.
−Removed: Warrant C-25 is for 200 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of June 23, 2022.
−Removed: On June 30, 2020 Warrant C-26 was issued in connection to the issuance of $2,000 of the senior convertible notes.
−Removed: Warrant C-26 is for 200 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of June 30, 2022.
−Removed: On June 30, 2020 Warrant C-21 was issued in connection to the purchase of $570,000 of the senior convertible notes.
−Removed: Warrant C-21 is for 57,000 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of June 30, 2022.
−Removed: On August 19, 2020 Warrant C-28 was issued in connection to the purchase of $2,081,273 of the senior convertible notes.
−Removed: Warrant C-22 is for 208,127 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of August 19, 2022.
−Removed: On August 26, 2020 Warrant C-22 was issued in connection to the purchase of $150,000 of the senior convertible notes.
−Removed: Warrant C-22 is for 15,000 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of August 26, 2022.
−Removed: On September 8, 2020 Warrant C-14 was issued in connection to the purchase of $134,367 of the senior convertible notes.
−Removed: Warrant C-14 is for 13,437 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of September 8, 2022.
−Removed: On September 14, 2020 Warrant C-29 was issued in connection to the purchase of $105,000 of the senior convertible notes.
−Removed: Warrant C-29 is for 10,500 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of September 14, 2022.
−Removed: On September 14, 2020 Warrant C-30 was issued in connection to the purchase of $105,000 of the senior convertible notes.
−Removed: Warrant C-30 is for 10,500 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of September 14, 2022.
−Removed: On September 16, 2020 Warrant C-31 was issued in connection to the purchase of $105,000 of the senior convertible notes.
−Removed: Warrant C-31 is for 10,500 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of September 16, 2022.
−Removed: On September 29, 2020 Warrant C-32 was issued in connection to the purchase of $105,000 of the senior convertible notes.
−Removed: Warrant C-32 is for 10,500 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of September 29, 2022.
−Removed: On September 30, 2020 Warrant C-33 was issued in connection to the purchase of $105,000 of the senior convertible notes.
−Removed: Warrant C-33 is for 10,500 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of September 30, 2022.
−Removed: On October 20, 2020 Warrant C-34 was issued in connection to the purchase of $500,000 of the senior convertible notes.
−Removed: Warrant C-34 is for 50,000 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of October 20, 2022.
−Removed: On November 17, 2020 Warrant C-35 was issued in connection to the purchase of $550,000 of the senior convertible notes.
−Removed: Warrant C-35 is for 55,000 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of November 17, 2022.
−Removed: On December 30, 2020 Warrant C-36 was issued in connection to the purchase of $500,000 of the senior convertible notes.
−Removed: Warrant C-36 is for 50,000 warrant shares.
−Removed: The warrants carry an exercise price of $1.50 and an expiration date of December 30, 2022.
−Removed: On January 26, 2021, the Company issued Common Stock Purchase Warrant “A-10” for rare earth capture advisory.
−Removed: The warrant provides the option to purchase 10,000 Class A Common Shares at a price of $2.05.
−Removed: The warrants expire on January 26, 2024.
−Removed: On February 2, 2021, the Company issued Common Stock Purchase Warrant “C-37” in conjunction with the issuance of $600,000 convertible note.
−Removed: The warrant provides the option to purchase 60,000 Class A Common Shares at a price of $1.50.
−Removed: The warrants expire on February 2, 2023.
−Removed: On February 7, 2021, the Company issued Common Stock Purchase Warrant “A-11” for rare earth processing advisory.
−Removed: The warrant provides the option to purchase 50,000 Class A Common Shares at a price of $4.25.
−Removed: The warrants expire on February 7, 2026.
−Removed: On March 11, 2021, the Company issued Common Stock Purchase Warrant “C-38” in conjunction with a restricted stock purchase.
−Removed: The warrant provides the option to purchase 42,500 Class A Common Shares at a price of $5.00.
−Removed: The warrants expire on March 11, 2023.
−Removed: On March 12, 2021, the Company issued Common Stock Purchase Warrant “C-39” in conjunction with a restricted stock purchase.
−Removed: The warrant provides the option to purchase 42,500 Class A Common Shares at a price of $5.00.
−Removed: The warrants expire on March 12, 2023.
−Removed: On March 15, 2021, the Company issued Common Stock Purchase Warrant “C-39” in conjunction with consulting services.
−Removed: The warrant provides the option to purchase 75,000 Class A Common Shares at a price of $4.59.
−Removed: The warrants expire on March 15, 2026.
−Removed: On March 16, 2021, the Company issued Common Stock Purchase Warrant “C-40” in conjunction with a restricted stock purchase.
−Removed: The warrant provides the option to purchase 21,250 Class A Common Shares at a price of $5.00.
−Removed: The warrants expire on March 16, 2023.
−Removed: On June 9, 2021, the Company issued Common Stock Purchase Warrant “C-38” in conjunction with a common stock offering.
−Removed: The warrant provides the option to purchase 2,150,000 Class A Common Shares at a price of $3.50.
−Removed: The warrants expire on June 9, 2026.
−Removed: On June 9, 2021, the Company issued Common Stock Purchase Warrant “C-39” in conjunction with a common stock offering.
−Removed: The warrant provides the option to purchase 2,150,000 Class A Common Shares at a price of $3.50.
−Removed: The warrants expire on June 9, 2026.
−Removed: On July 20, 2021, the Company issued 150,000 Employee Stock options under the current plan.
−Removed: The options vest over their 7-year life.
−Removed: On September 3, 2021, the Company issued 100,000 Employee Stock options under the current plan.
−Removed: The options vest over their 7-year life.
−Removed: During December 2021, the Company issued 1,020,000 Employee Stock options under the current plan.
+Added: During 2023, the Company issued 4,236,500 Employee Stock options under the current plan.
The individual option awards vest over a period of 1 to 7 years.
+Added: During 2023, the Company issued 330,000 warrants under the current plan.
+Added: The individual warrants vest on the grant date.
+Added: The warrants have an exercise price between $1.00 and $1.81 and have an expiration date between September 13, 2023 and July 27, 2028.
+Added: During 2024, the Company issued 1,575,000 Employee Stock options under the current plan.
+Added: The individual option awards vest over a period of 1 to 10 years.
+Added: During 2024, the Company issued 100,000 warrants under the current plan.
+Added: The individual warrants vest on the grant date.
+Added: The warrant has an exercise price of $0.54 and an expiration date of August 29, 2031.
During the period the options and warrants are outstanding, we will reserve from our authorized and unissued common stock a sufficient number of shares to provide for the issuance of shares of common stock underlying the options and warrants upon the exercise of the options and warrants.
5 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.